A high-risk airway mycobiome characterises frequent COPD exacerbators

P. Tiew (Singapore, Singapore), A. Dicker (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), M. Poh (Kuala Lumpur, Malaysia), S. Pang (Singapore, Singapore), S. Matta (Singapore, Singapore), B. Chua (Singapore, Singapore), H. Xu (Singapore, Singapore), M. Koh (Singapore, Singapore), A. Tee (Singapore, Singapore), J. Abisheganaden (Singapore, Singapore), F. Chew (Singapore, Singapore), B. Miller (Pennsylvania, United States of America), R. Tal-Singer (Pennsylvania, United States of America), J. Chalmers (Dundee, United Kingdom), S. Chotirmall (Singapore, Singapore)

Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Session: Airway infection: the microbiome and beyond
Session type: Oral Presentation
Number: 4933
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Tiew (Singapore, Singapore), A. Dicker (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), M. Poh (Kuala Lumpur, Malaysia), S. Pang (Singapore, Singapore), S. Matta (Singapore, Singapore), B. Chua (Singapore, Singapore), H. Xu (Singapore, Singapore), M. Koh (Singapore, Singapore), A. Tee (Singapore, Singapore), J. Abisheganaden (Singapore, Singapore), F. Chew (Singapore, Singapore), B. Miller (Pennsylvania, United States of America), R. Tal-Singer (Pennsylvania, United States of America), J. Chalmers (Dundee, United Kingdom), S. Chotirmall (Singapore, Singapore). A high-risk airway mycobiome characterises frequent COPD exacerbators. 4933

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD
Source: Eur Respir J, 57 (3) 2002050; 10.1183/13993003.02050-2020
Year: 2021



Comparison of small airways disease measures between frequent and infrequent COPD exacerbators
Source: International Congress 2019 – Respiratory function assessment in disease
Year: 2019

Characterisation of the bronchial epithelium in COPD frequent exacerbators
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019

The study of airway microbiome and mycobiome of COPD and AECOPD patients
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018


Frequent COPD exacerbators are not a stabile phenotype
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019


The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013

A study of the airway mycobiome in COPD patients and controls
Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD
Year: 2019



Exacerbation phenotypes of frequent versus non-frequent exacerbators among severe asthma patients
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019


Spirometry quality in patients with COPD exacerbation, related to the “frequent exacerbator” phenotype
Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function
Year: 2013

The lower airways microbiome in patients with IPF and COPD
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019

The prevelance of chronic nasal symptoms in COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 264s
Year: 2002

Variability and effects of bronchial colonisation in patients with moderate COPD
Source: Eur Respir J 2010; 35: 295-302
Year: 2010



Airway pathology in COPD compared to that in smokers with asthma
Source: Annual Congress 2008 - Smokers with asthma versus COPD: differences and similarities
Year: 2008


The airway microbiota and exacerbations of COPD
Source: ERJ Open Res, 6 (3) 00168-2020; 10.1183/23120541.00168-2020
Year: 2020



Frequent exacerbators among patients with COPD - prevalence and stability
Source: International Congress 2017 – Markers of COPD progression
Year: 2017


Ex-smokers with frequent COPD exacerbations have low FENO in stable condition
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019

Under-diagnosis and under-evaluation of the severity of COPD in at-risk subjects
Source: Eur Respir J 2004; 24: Suppl. 48, 287s
Year: 2004

Occurrence and impact of upper airways symptoms in never smoker COPD patients
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017


Characteristics and mechanisms of bronchial hyper-responsiveness in symptomatic subjects with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 209s
Year: 2003

The clinical importance of small airway involvement in patients with asthma and COPD
Source: International Congress 2019 – PG12 Recent advances in small airways diseases in patients with asthma and COPD
Year: 2019